allo_geneic•11 hours agoFlag
If one was to look at the Muscle Injury Hip-Replacement Indication alone, then Pluristem would have the Industrial capacity to produce 2 Billion dollars worth of PLX Cells for Hip Replacement Surgery from their 3-D expansion plant in Haifa per year. As we learned on Tuesday that it may only require between 100 to 150 million PLX cells for a single dose of PLX cells. With that said, now try to be a Wall Street Analyst and try to predict the future growth of Pluristem as a company with 100 plus indications! Not going to happen, as no Wall Street Analyst is going to hang their reputation around the neck of Pluristem even though a 2 year reasonable evaluation may be in the $ 25.00 range ! Less
- 2 Replies to allo_geneic
-
SWEET!
Sentiment: Strong Buy
-
Now, uneducated Investors can now begin to fully understand why no analysts is going to go out on a limb and put their reputation on the line for Pluristem and put a $ 25.00 Dollar price target on Pluristem as they know it is possible with just 1 or 2 licensing deals as they do not want to look foolish. If it takes 6-12 months! My guess it will happen in less then 8 months. I predict Pluristem will reach $ 22.00 in less than 8 months. Allo B Thy Name ! Less
